Cue Biopharma Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015
Revenue	5.49	1.25	14.94	3.15	3.46	1.14	0	0	0
Revenue Growth (YoY)	340.96%	-91.67%	373.68%	-8.79%	202.67%	-	-	-	-
Gross Profit	5.49	1.25	14.94	3.15	3.46	1.14	0	0	0
Selling, General & Admin	16.68	16.17	17.31	14.65	12.74	11.3	4.33	1.97	0.43
Research & Development	40.8	38.58	41.35	33.55	27.49	28.54	18.9	5.69	1.5
Operating Expenses	57.48	54.75	58.65	48.2	40.23	39.84	23.23	7.66	1.93
Operating Income	-51.99	-53.5	-43.71	-45.04	-36.77	-38.7	-23.23	-7.66	-1.93
Interest Expense / Income	1.25	0.71	0	0	0	0	0	0	0
Other Expense / Income	-2.5	-1.21	-0.05	-0.46	-0.48	-0.54	-0	-0	-
Pretax Income	-50.73	-53.01	-43.67	-44.58	-36.29	-38.16	-23.23	-7.66	-1.93
Income Tax	0	0	0.5	0.21	0.41	0.83	0	0	0
Net Income	-50.73	-53.01	-44.16	-44.78	-36.7	-38.98	-23.23	-7.66	-1.93
Shares Outstanding (Basic)	46	36	31	29	22	20	11	7	6
Shares Outstanding (Diluted)	46	36	31	29	22	20	11	7	6
Shares Change	28.35%	13.95%	9.05%	30.16%	9.48%	87.60%	44.38%	31.37%	-
EPS (Basic)	-1.11	-1.49	-1.41	-1.56	-1.66	-1.94	-2.16	-1.03	-0.34
EPS (Diluted)	-1.11	-1.49	-1.41	-1.56	-1.66	-1.94	-2.16	-1.03	-0.34
Free Cash Flow	-39.96	-41.97	-39.73	-33.09	-30.72	-28.27	-13.17	-6.48	-2.41
Free Cash Flow Per Share	-0.87	-1.18	-1.27	-1.15	-1.39	-1.40	-1.23	-0.87	-0.43
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	-	-	-
Operating Margin	-947.03%	-4297.35%	-292.56%	-1427.96%	-1063.21%	-3386.71%	-	-	-
Profit Margin	-924.10%	-4257.83%	-295.56%	-1419.79%	-1061.18%	-3411.53%	-	-	-
Free Cash Flow Margin	-727.85%	-3371.16%	-265.90%	-1049.01%	-888.17%	-2473.75%	-	-	-
EBITDA	-46.05	-50.49	-42.41	-43.52	-35.48	-37.4	-22.81	-7.46	-1.88
EBITDA Margin	-838.83%	-4055.50%	-283.83%	-1379.73%	-1025.80%	-3272.81%	-	-	-
Depreciation & Amortization	3.44	1.81	1.26	1.06	0.81	0.76	0.42	0.2	0.04
EBIT	-49.49	-52.3	-43.67	-44.58	-36.29	-38.16	-23.23	-7.66	-1.93
EBIT Margin	-901.42%	-4200.56%	-292.25%	-1413.26%	-1049.25%	-3339.33%	-	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).